V. Sweere
Papers
1
Total Citations
3
H-Index
1
About
V. Sweere is a rising leader in molecular imaging and urologic oncology, whose work is redefining risk stratification for prostate cancer. Their research centers on the clinical application of PSMA PET/CT, particularly its prognostic power in guiding post-surgical outcomes. In their landmark 2025 study, Sweere demonstrated that PSMA PET/CT-based local staging significantly outperforms conventional imaging for predicting biochemical recurrence after radical prostatectomy. By establishing a clear link between PSMA PET/CT characteristics and biochemical recurrence-free survival, this work provides surgeons and oncologists with a more precise tool for early risk assessment and treatment planning. Though still early in their career, Sweere’s contributions are already shaping how the field approaches local staging—moving beyond traditional anatomical imaging toward molecularly informed prognostication. Their findings, which have garnered immediate attention and citations, signal a shift toward integrating PSMA PET/CT into standard preoperative evaluation. For students and researchers, Sweere’s work exemplifies how targeted molecular imaging can unlock deeper insights into cancer biology and improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1